Biodegradable Osteogenic Scaffold for Load-Bearing Bone Defects
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating critical-sized bone defects, such as those caused by cancer or trauma, face challenges in achieving adequate bone regeneration while providing sufficient mechanical support for load-bearing applications. Existing scaffolds made from materials like hydroxyapatite and beta-tricalcium phosphate are too brittle for practical load-bearing but become less osteogenic when strengthened.
Innovation Solution
The proposed solution involves using a biodegradable osteogenic scaffold positioned within a biodegradable sleeve, coupled to a fixation member, which is attached to both proximal and distal bone structures. This configuration allows for initial mechanical support while the scaffold facilitates bone growth, eventually degrading as new bone heals the defect.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If scaffolds are made from osteogenic materials like hydroxyapatite and beta-tricalcium phosphate, then bone regeneration capability is improved, but mechanical strength for load-bearing is reduced
Solution Approach 1:
The patent employs composite materials combining hydroxyapatite (HAp) and polycaprolactone (PCL) in a 3:1 ratio. HAp provides osteogenic properties and bone regeneration capability, while PCL contributes mechanical strength and structural support. This composite approach resolves the contradiction by integrating materials with complementary properties to achieve both biological functionality and mechanical adequacy for load-bearing applications
Solution Approach 2:
The scaffold exhibits local quality variations through its composite structure, where HAp-rich regions provide osteogenic activity at the bone interface, while PCL-rich regions provide mechanical strength in load-bearing zones. This spatial differentiation of material properties allows simultaneous optimization of bone regeneration and mechanical performance in different locations of the same scaffold
2Strength
If permanent metal fixation is used, then mechanical support is improved, but long-term complications and reoperations increase
Solution Approach 1:
The patent employs biodegradable PCL as a temporary structural support that provides necessary mechanical strength during the bone healing period, then gradually degrades and is replaced by natural bone. This temporary support strategy eliminates the need for permanent metal implants, avoiding long-term complications such as screw loosening, plate fracture, and infection while maintaining adequate mechanical support when needed
Solution Approach 2:
The PCL material undergoes parameter changes over time through controlled biodegradation, transitioning from providing primary mechanical support to gradually transferring load to regenerated bone. This time-dependent parameter change allows the fixation device to adapt its mechanical properties to match the healing progression, eliminating the need for permanent implants
3Strength
If scaffold load-bearing capability is enhanced, then structural strength is improved, but osteogenic character is reduced
Solution Approach 1:
The HAp-PCL composite scaffold resolves this contradiction by assigning different functional roles to each material component. PCL provides the structural strength and load-bearing capability, while HAp particles dispersed within the PCL matrix provide osteogenic character and promote bone formation. The composite structure allows simultaneous achievement of mechanical strength and osteogenicity that neither material could achieve alone
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables effective bone healing and load-bearing capabilities without the need for permanent metal implants, as the biodegradable components degrade safely, leaving only natural bone behind.
Implementation Method 1
Scaffolds made with biomaterials like hydroxyapatite (HAp), beta-tri-calcium phosphate (β-TCP) and numerous other forms of calcium phosphates and derivatives thereof are highly osteogenic
Implementation Method 2
Scaffolds made with biomaterials like hydroxyapatite (HAp), beta-tri-calcium phosphate (β-TCP) and numerous other forms of calcium phosphates and derivatives thereof are highly osteogenic
Implementation Method 3
Scaffolds made with biomaterials like hydroxyapatite (HAp), beta-tri-calcium phosphate (β-TCP) and numerous other forms of calcium phosphates and derivatives thereof are highly osteogenic
Implementation Method 4
They release calcium during degradation, which supports bone formation
Implementation Method 5
biodegradable osteogenic scaffold... biodegradable components degrade safely, leaving only natural bone behind
Data Source
AI summary
A method for treating a bone defect extending between a proximal bone structure and a distal bone structure of a patient may include resecting a region of bone between the proximal bone structure and the distal bone structure and encompassing the bone defect, positioning a biodegradable osteogenic scaffold within a biodegradable sleeve, coupling the biodegradable sleeve to a fixation member, positioning the biodegradable sleeve between the proximal bone structure and the distal bone structure, and attaching the fixation member to each of the proximal bone structure and the distal bone structure.